Integrative Evidence on Sesame Supplementation for Cardiometabolic Risk Factors Relevant to Retinopathy
International Journal of Medical Sciences · 2026
DOI: 10.7150/ijms.123717 ↗At a glance
Metaanalyse in International Journal of Medical Sciences, 2026. Written by Wu-Hsien Kuo and 4 co-authors. Institution: Department of Gastroenterology and Hepatology, Yuan Sheng Branch, Yuan Rung Hospital, Yuanlin, Changhua, 510007, Taiwan. Major MEDLINE topics: Diabetic Retinopathy, Dietary Supplements, Sesamum. The full text is freely available in PubMed Central.
Abstract (original language)
Background
Cardiometabolic disorders, such as diabetes, hypertension, dyslipidemia, retinopathy, and non-alcoholic fatty liver disease, present significant health challenges globally. Recent evidence suggests that sesame (Sesamum indicum L.) supplementation may offer beneficial effects in modulating various cardiometabolic risk factors, although findings from clinical trials have been inconsistent.
Objective
This meta-analysis aims to systematically assess the effects of sesame supplementation on multiple cardiometabolic parameters, including lipid profiles, blood pressure, glycemic control, liver enzyme levels, inflammatory biomarkers, body weight, and body mass index (BMI), with the goal of evaluating its potential as an adjunctive therapy for clinical retinopathy.
Methods
A comprehensive literature search was conducted across multiple databases through July 2025 to identify randomized controlled trials (RCTs) that compared sesame supplementation with placebo or active controls on cardiometabolic outcomes.
Results
Pooled effect sizes were calculated using a random-effects model. A total of 10 studies involving 441 participants were included in the meta-analysis. Sesame supplementation significantly reduced both systolic and diastolic blood pressure. Improvements were also observed in glycemic control, with reductions in fasting blood glucose and HbA1c levels. Further-more, sesame intake was associated with a significant reduction in liver enzyme levels, particularly alanine aminotransferase (ALT). Subgroup analyses revealed that the effects did not increase with longer durations of sesame supplementation.
Conclusions
This meta-analysis provides evidence supporting the beneficial effects of sesame supplementation in improving various cardiometabolic risk factors. Incorporating sesame products into dietary strategies may offer a promising adjunctive intervention for managing cardiometabolic disorders and retinopathy associated with these disorders.
Subjects
MeSH terms (MEDLINE)
Author keywords
Substances
Authors and institutions
- Department of Gastroenterology and Hepatology, Yuan Sheng Branch, Yuan Rung Hospital, Yuanlin, Changhua, 510007, Taiwan.
- Department of Cardiology, Yuan Rung Hospital, Yuanlin, Changhua, 510005, Taiwan.
- Center for Geriatrics & Gerontology, Taichung Veterans General Hospital, Taichung 407219, Taiwan.
- Division of Neurology, Taichung Veterans General Hospital, Taichung 407219, Taiwan.
- School of Medicine, Chung Shan Medical University, Taichung 40201, Taiwan.
- Department of Anatomy, School of Medicine, Chung Shan Medical University, Taichung 40201, Taiwan.
Cite
APA
Kuo, W. H., Chang, K. S., Kuo, F. H., Cheng, K. P., & Tsai, R. Y. (2026). Integrative Evidence on Sesame Supplementation for Cardiometabolic Risk Factors Relevant to Retinopathy. International Journal of Medical Sciences. https://doi.org/10.7150/ijms.123717
Vancouver
Kuo WH, Chang KS, Kuo FH, Cheng KP, Tsai RY. Integrative Evidence on Sesame Supplementation for Cardiometabolic Risk Factors Relevant to Retinopathy. International Journal of Medical Sciences. 2026. doi:10.7150/ijms.123717
BibTeX
@article{Kuo2026,
author = {Kuo, Wu-Hsien and Chang, Ko-Shih and Kuo, Fu-Hsuan and Cheng, Kuan-Po and Tsai, Ru-Yin},
title = {Integrative Evidence on Sesame Supplementation for Cardiometabolic Risk Factors Relevant to Retinopathy},
journal = {International Journal of Medical Sciences},
year = {2026},
doi = {10.7150/ijms.123717}
}
EUVIMED